Thalassaemia treatment gets EU approval
New data from Parkinson’s disease trial
Restoring the “longevity protein”
Positive topline results from phase 2 recurrent ovarian cancer trial
Low-cost vial could prevent wasted vaccines
Thyroid key to prostate cancer treatment?
Resistant hypertension trial meets endpoint
Gene therapy treatment for patients with Crigler–Najjar syndromeÂ
New Genmab data shows anti-tumour activity
Endpoints met at 12 months for eye treatment
Improved cough-detection tech for health monitoring
FDA approves lupus nephritis treatment